NVAX Jul 2024 14.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:32AM EDT. Market open.
| Previous close | 0.6700 |
| Open | 0.6700 |
| Bid | 0.5200 |
| Ask | 0.8100 |
| Strike | 14.50 |
| Expiry date | 2024-07-26 |
| Day's range | 0.6700 - 0.7300 |
| Contract range | N/A |
| Volume | |
| Open interest | 48 |
Investor's Business DailyThe FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Novavax stock has pulled back after hitting a nearly two-year high earlier this month. Is NVAX stock a buy right now?
GuruFocus.comInsider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 61,760 shares of Novavax Inc. Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
ZacksNovavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
© 2024 Yahoo. All rights reserved.